iBio, Inc. (NYSEMKT:IBIO)

CAPS Rating: 2 out of 5

A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 7/31/2012 7:25:58 AM : Underperform Start Price: $1.17 IBIO Score: +39.17

New 1 star.

Featured Broker Partners


Advertisement